Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antigen of Haemophilus influenzae type b (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antigen of Bordetella pertussis (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antigen of Corynebacterium diphtheriae (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antigen of Clostridium tetani (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
|
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens (medicinal product) |
Is a |
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens (medicinal product) |
Is a |
Vaccine product containing Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens (medicinal product) |
Plays role |
Active immunity stimulant role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|